Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: The Himmel Group

This article was originally published in The Rose Sheet

Executive Summary

The Himmel Group: Retains TM Capital Corp. to investigate new branded consumer product "opportunities." Himmel, which markets the Ovaltine powdered drink mix, is interested in personal care items, cosmetics, OTC drugs, foods, beverages, household products and pet supplies/food items. Products of interest would have sales of up to $100 mil., be "advertisable" on TV and radio and have retail distribution through channels including food and grocery stores, mass merchandisers, club stores and drug stores. Himmel would consider "collaboration structures" including acquisitions, licensing, incentive market and media arrangements. The company exited the H&BA market in 1996 when it sold the Gold Bond Medicated Powder line to Chattem for $40 mil. ("The Rose Sheet" April 15, 1996, p. 7)...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts